The report states that medical cannabis makes up the biggest part of the market segment, taking up most of the revenue shares based on 2019 figures at 71%. This is attributed to the increasing adoption of cannabis as a legitimate alternative to pharmaceuticals, especially for treating life-threatening conditions including cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and neurological disorders among others. There is also a rising demand for effective painkillers as well as chronic pain medications for the elderly, and this is where much product demand is expected to be seen.
Low-dose THC beverages typically contain somewhere between 2 and 5 mg of THC per serving.…
A few dozen strangers answered one question, and here's what they told me. Cannabis rarely…
Federal officials admitted under oath at the DEA marijuana rescheduling hearing that the 54-year-old test…
Discover why Donald Trump lost the 2026 midterms, how the hemp and cannabis industries survived…
On October 29, Fox News ran a column by Dr. Marc Siegel, the network’s senior medical…
Is cannabis a miracle cure or a gateway to ruin? We break down the latest…